Using DU145 metastatic prostate cancer cells as the experimental model, it was demonstrated that inhibition of the p130Cas-CrkII pathway is crucial for the KAI1/CD82-mediated suppression of cell motility in DU145 cells [81]. The gene discussed is BCAR1; the disease is Familial prostate cancer.